News
14 Jul 2023
EDQM Grants C2 PHARMA CEP Approval for Commercial Sale of Cyclopentolate Hydrochloride
C2 Pharma receives the European Directorate for the Quality of Medicines and Healthcare second Certificate of Suitability for Cyclopentolate Hydrochloride, a significant achievement for our dedicated team.
The #cep approved by the EDQM is the second existing approval for Cyclopentolate Hydrochloride and the only approval allowing our #gmp-certified manufacturing site to supply to other markets.
Mentioned Companies
C-squared PHARMA Limited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance